Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.
Dauvilliers Y, Mignot E, Del Río Villegas R, Du Y, Hanson E, Inoue Y, Kadali H, Koundourakis E, Meyer S, Rogers R, Scammell TE, Sheikh SI, Swick T, Szakács Z, von Rosenstiel P, Wu J, Zeitz H, Murthy NV, Plazzi G, von Hehn C.
N Engl J Med. 2023 Jul 27;389(4):309-321. doi: 10.1056/NEJMoa2301940.
PMID:37494485
Nutritional Modulation of Sleep Latency, Duration, and Efficiency: A Randomized, Repeated-Measures, Double-Blind Deception Study.
Langan-Evans C, Hearris MA, Gallagher C, Long S, Thomas C, Moss AD, Cheung W, Howatson G, Morton JP.
Med Sci Sports Exerc. 2023 Feb 1;55(2):289-300. doi: 10.1249/MSS.0000000000003040. Epub 2022 Sep 9.
Objective evaluation of excessive daytime sleepiness.
Taillard J, Micoulaud-Franchi JA, Martin VP, Peter-Derex L, Vecchierini MF.
Neurophysiol Clin. 2024 Apr;54(2):102938. doi: 10.1016/j.neucli.2023.102938. Epub 2024 Feb 23.
PMID:38401239
Targeted Hypoglossal Nerve Stimulation for Patients With Obstructive Sleep Apnea: A Randomized Clinical Trial.
Schwartz AR, Jacobowitz O, Eisele DW, Mickelson SA, Miller MB, Oliven A, Certal V, Hopp ML, Winslow DH, Huntley TC, Nachlas NE, Pham LV, Gillespie MB, Weeks BH, Lovett EG, Shen J, Malhotra A, Maurer JT.
JAMA Otolaryngol Head Neck Surg. 2023 Jun 1;149(6):512-520. doi: 10.1001/jamaoto.2023.0161.
PMID:37022679
Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial.